BCK Capital Management’s NEOPHOTONICS CORP NPTN Stock Holding History
Bought
Maintained
Sold
Other funds holding NPTN
BCK Capital Management's NPTN Position: Q3 2022 in Review
BCK Capital Management sold out of NEOPHOTONICS CORP (NPTN) in Q3 2022, closing a stake of 259,809 shares — an estimated $4.09M sold.
BCK Capital Management first reported a position in NPTN in Q4 2021 and held it in 3 quarters. The position peaked at $4.09M in Q2 2022. 2 funds tracked by Wall St. Rank hold NPTN as of Q3 2022.
- BCK Capital Management reported no remaining NEOPHOTONICS CORP position as of Q3 2022 after selling out during the quarter.
- BCK Capital Management sold 259,809 NEOPHOTONICS CORP shares in Q3 2022, an estimated $4.09M.
- BCK Capital Management first reported a position in NEOPHOTONICS CORP in Q4 2021 and held it in 3 quarters.
- BCK Capital Management's NEOPHOTONICS CORP position peaked at $4.09M in Q2 2022.
- 2 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q3 2022.
Based on BCK Capital Management's 13F filing for Q3 2022, filed 8 Nov 2022.